Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention

Texas Heart Institute Journal

Volumn 35, Issue 4, 2008, Pages 439-446

  Forman, Mervyn B ^a   Hou, Dongming ^a   Jackson, Edwin K ^b  

^a Saint Joseph's Hospital of Atlanta   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine administration dosage physiology therapeutic use; Angioplasty, transluminal, percutaneous coronary adverse effects methods; Atherosclerosis complications therapy; Cardiotonic agents administration dosage therapeutic use; Coronary vessels drug effects; Creatine kinase blood; Dose response relationship, drug; Graft occlusion, vascular therapy; Myocardial reperfusion methods; Treatment outcome; Vasodilator agents administration dosage therapeutic use

Indexed keywords

ADENOSINE; CALCIUM; CREATINE KINASE; GLYCERYL TRINITRATE; HEPARIN; NITROPRUSSIDE SODIUM; TROPONIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; AORTA VALVE STENOSIS; ARTICLE; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DRUG HALF LIFE; ELECTROCARDIOGRAM; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HUMAN; IMPAIRED TISSUE PERFUSION; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; ST SEGMENT ELEVATION;

ACUTE DISEASE; ADENOSINE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; GRAFT SURVIVAL; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; PERFUSION; VASODILATOR AGENTS;

EID: 58849115369     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ali OA, Bhindi R, McMahon AC, Brieger D, Kritharides L, Lowe HC. Distal protection in cardiovascular medicine: current status. Am Heart J 2006;152(2):207-16.
2. Johansen O, Brekke M, Stromme JH, Valen V, Seljeflot I, Skjaeggestad O, Arnesen H. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J 1998;19(1):112-7.
3. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 2000;101(6):604-10.
4. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105(5):656-62.
5. Leosco D, Fineschi M, Pierli C, Fiaschi A, Ferrara N, Bianco S, et al. Intracoronary serotonin release after high-pressure coronary stenting. Am J Cardiol 1999;84(11):1317-22.
6. Taylor AJ, Bobik A, Richards M, Kaye D, Raines G, Gould P, Jennings G. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease. Am Heart J 2004;148(2):e10.
7. Forman MB, Stone GW, Jackson EK. Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovasc Drug Rev 2006;24(2):116-47.
8. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335(18):1342-9.
9. Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, et al.; Italian 'Atherosclerosis, Thrombosis, and Vascular Biology' and 'Society for Invasive Cardiology-GISE' Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 2005;26(15):1494-8.
10. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103(23):2780-3.
11. Gibson CM, Schomig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation 2004;109(25):3096-105.
12. Forman MB, Jackson EK. Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine. Clin Cardiol 2007;30(11):583-5.
13. Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation 2006;113(22):2651-6.
14. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, et al.; Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293(9):1063-72.
15. Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Klovgaard L, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008;51(9):899-905.
16. Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator. Circulation 1989;80(6):1718-25.
17. Minamino T, Kitakaze M, Asanuma H, Tomiyama Y, Shiraga M, Sato H, et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest 1998;101(8):1643-53.
18. Lee CH, Low A, Tai BC, Co M, Chan MY, Lim J, et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study. Eur Heart J 2007;28(1):19-25.
19. Desmet WJ, Dens J, Coussement P, Van de Werf F. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart 2002;88(3):293-5.
20. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000;101(18):2154-9.
21. Assali AR, Sdringola S, Ghani M, Denkats AE, Yepes A, Hanna GP, et al. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon. Catheter Cardiovasc Interv 2000;51(1):27-32.
22. Gibson CM. Has my patient achieved adequate myocardial reperfusion? Circulation 2003;108(5):504-7.
23. Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv 2008;71(3):283-9.
24. Hanna GP, Yhip P, Fujise K, Schroth GW, Rosales OR, Anderson HV, Smalling RW. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 1999;48(3):275-8.
25. Fischell TA, Carter AJ, Foster MT, Hempsall K, DeVries J, Kim DH, Kloostra A. Reversal of "no reflow" during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet Cardiovasc Diagn 1998;45(4):360-5.
26. Sdringola S, Assali A, Ghani M, Yepes A, Rosales O, Schroth GW, et al. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon. Catheter Cardiovasc Interv 2000;51(4):394-9.
27. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol 2002;14(6):299-302.
28. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89(6):2514-8.
29. Vijayalakshmi K, Whittaker VJ, Kunadian B, Graham J, Wright RA, Hall JA, et al. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart 2006;92(9):1278-84.
30. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001;37(5):1335-43.